{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:36:22Z","timestamp":1761766582816,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ajp.2019.07.048","type":"journal-article","created":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T18:00:45Z","timestamp":1564250445000},"page":"156-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["RAADs (Rapidly Acting Anti-depressants)\u2014A quantum leap?"],"prefix":"10.1016","volume":"44","author":[{"given":"Ahmed","family":"Naguy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1-3","key":"10.1016\/j.ajp.2019.07.048_bib0005","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0165-0327(02)00404-4","article-title":"Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trials","volume":"79","author":"Ballesteros","year":"2004","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.ajp.2019.07.048_bib0010","first-page":"1","article-title":"Is trazodone more effective than clomipramine in major depressed outpatients? A single-blind study with intravenous and oral administration","volume":"30","author":"Buoli","year":"2017","journal-title":"CNS Spectr."},{"issue":"2","key":"10.1016\/j.ajp.2019.07.048_bib0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/jamapsychiatry.2017.3739","article-title":"Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized controlled trial","volume":"75","author":"Daly","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.ajp.2019.07.048_bib0020","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1600-0447.1997.tb09926.x","article-title":"Electroconvulsive therapy vs. Paroxetine in treatment-resistant depression- a randomized study","volume":"96","author":"Folkerts","year":"1997","journal-title":"Acta Psychiatr. Scand."},{"issue":"6","key":"10.1016\/j.ajp.2019.07.048_bib0025","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00004714-198912000-00026","article-title":"Amphetamine, but not methylphenidate, predicts antidepressant response","volume":"9","author":"Gwirtsman","year":"1989","journal-title":"J. Clin. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.ajp.2019.07.048_bib0030","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1586\/ern.10.83","article-title":"Sleep deprivation in depression","volume":"10","author":"Hemmeter","year":"2010","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ajp.2019.07.048_bib0035","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0140-6736(18)31551-4","article-title":"Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials","volume":"392","author":"Meltzer-Brody","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ajp.2019.07.048_bib0040","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ajp.2018.06.014","article-title":"Treatment-resistant depression: a plea to mull over!","volume":"36","author":"Naguy","year":"2018","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.ajp.2019.07.048_bib0045","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/01.pra.0000462606.17725.93","article-title":"Randomized proof of concept trial of GLYX-13, an N-methyl-D-aspartate receptor glycine site partial agonist, in major depressive disorder nonresponsive to a previous antidepressant agent","volume":"21","author":"Preskorn","year":"2015","journal-title":"J. Psychiatr. Pract."},{"issue":"12","key":"10.1016\/j.ajp.2019.07.048_bib0050","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Raid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ajp.2019.07.048_bib0055","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an n-methyl-d-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201819303077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201819303077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:34:26Z","timestamp":1761755666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201819303077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":11,"alternative-id":["S1876201819303077"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2019.07.048","relation":{},"ISSN":["1876-2018"],"issn-type":[{"type":"print","value":"1876-2018"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RAADs (Rapidly Acting Anti-depressants)\u2014A quantum leap?","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2019.07.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}